United Kingdom

People: Aeterna Zentaris Inc (AEZS.OQ)

AEZS.OQ on NASDAQ Stock Exchange Capital Market

19 Jul 2019
Change (% chg)

$-0.04 (-1.57%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Ward, Michael 

Mr. Michael Ward is President, Chief Executive Officer, Director of the Company. He has over 30 years of executive and legal experience in the health care, pharmaceutical and technology industries. Most recently, Mr. Ward served as chief compliance and legal officer and corporate secretary for Sagent Pharmaceuticals, a global specialty generic pharmaceutical company, and led its sale to Nichi-Iko Pharmaceutical Co. Ltd. for $736-million. Mr. Ward has served as strategic adviser to Benevolent Capital Partners for the last five years and is currently a partner with Outside GC LLC. Prior to Sagent Pharmaceuticals, Mr. Ward was vice-president, assistant general counsel of global compliance, ethics and litigation, and chief privacy officer at CDK Global. Mr. Ward has served in several executive roles and was responsible for business development, compliance, legal and operational matters in the health care, pharmaceutical and technology industries during his career. Mr. Ward graduated from Albion College and Case Western Reserve University law school.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --